FDA applicant

Renalytix Ai, Inc.

New York, NY1 decision2023–20230 recalls

FDA records 1 decision for Renalytix Ai, Inc. (New York, NY) in 2023: 1 De Novo grant. All are in product code QWZ (Prognostic Test For Assessment Of Chronic…). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Renalytix Ai, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2023high 1 (2023) · low 0 (2024)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2023.

FIG. 1 — Renalytix Ai, Inc. by year, 2023–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Renalytix Ai, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Renalytix Ai, Inc.

Which product codes does it file in?

What has FDA decided for it lately?